BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37386798)

  • 1. Psychotic symptoms in frontotemporal dementia with TDP-43 tend to be associated with type B pathology.
    Hirsch-Reinshagen V; Hercher C; Vila-Rodriguez F; Neumann M; Rademakers R; Honer WG; Hsiung GR; Mackenzie IR
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12921. PubMed ID: 37386798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcortical TDP-43 pathology patterns validate cortical FTLD-TDP subtypes and demonstrate unique aspects of C9orf72 mutation cases.
    Mackenzie IR; Neumann M
    Acta Neuropathol; 2020 Jan; 139(1):83-98. PubMed ID: 31501924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.
    Dedeene L; Van Schoor E; Vandenberghe R; Van Damme P; Poesen K; Thal DR
    Acta Neuropathol Commun; 2019 Dec; 7(1):189. PubMed ID: 31791419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology.
    Scarioni M; Gami-Patel P; Timar Y; Seelaar H; van Swieten JC; Rozemuller AJM; Dols A; Scarpini E; Galimberti D; ; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
    Ann Neurol; 2020 Jun; 87(6):950-961. PubMed ID: 32281118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.
    Scarioni M; Gami-Patel P; Peeters CFW; de Koning F; Seelaar H; Mol MO; van Swieten JC; ; Rozemuller AJM; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
    Brain; 2023 Jan; 146(1):307-320. PubMed ID: 35136978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing post-translational modifications in dominantly inherited frontotemporal dementias: FTLD-TDP Type A (GRN) vs Type B (C9orf72).
    Cracco L; Doud EH; Hallinan GI; Garringer HJ; Jacobsen MH; Richardson RM; Buratti E; Vidal R; Ghetti B; Newell KL
    Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12836. PubMed ID: 35836354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
    Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
    Mann DMA; Snowden JS
    Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappraisal of TDP-43 pathology in FTLD-U subtypes.
    Mackenzie IR; Neumann M
    Acta Neuropathol; 2017 Jul; 134(1):79-96. PubMed ID: 28466142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-incidental C9orf72 expansion mutation-related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt-Jakob disease.
    Klotz S; König T; Erdler M; Ulram A; Nguyen A; Ströbel T; Zimprich A; Stögmann E; Regelsberger G; Höftberger R; Budka H; Kovacs GG; Gelpi E
    Eur J Neurol; 2021 Mar; 28(3):1009-1015. PubMed ID: 33131137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts.
    Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok JB
    Neurology; 2012 Sep; 79(10):995-1001. PubMed ID: 22875086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the
    Devenney EM; Landin-Romero R; Irish M; Hornberger M; Mioshi E; Halliday GM; Kiernan MC; Hodges JR
    Neuroimage Clin; 2017; 13():439-445. PubMed ID: 28116236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations.
    Snowden JS; Rollinson S; Thompson JC; Harris JM; Stopford CL; Richardson AM; Jones M; Gerhard A; Davidson YS; Robinson A; Gibbons L; Hu Q; DuPlessis D; Neary D; Mann DM; Pickering-Brown SM
    Brain; 2012 Mar; 135(Pt 3):693-708. PubMed ID: 22300873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms.
    Naasan G; Shdo SM; Rodriguez EM; Spina S; Grinberg L; Lopez L; Karydas A; Seeley WW; Miller BL; Rankin KP
    Brain; 2021 Apr; 144(3):999-1012. PubMed ID: 33501939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype.
    Katisko K; Huber N; Kokkola T; Hartikainen P; Krüger J; Heikkinen AL; Paananen V; Leinonen V; Korhonen VE; Helisalmi S; Herukka SK; Cantoni V; Gadola Y; Archetti S; Remes AM; Haapasalo A; Borroni B; Solje E
    Alzheimers Res Ther; 2022 Oct; 14(1):151. PubMed ID: 36217158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration.
    Yousef A; Robinson JL; Irwin DJ; Byrne MD; Kwong LK; Lee EB; Xu Y; Xie SX; Rennert L; Suh E; Van Deerlin VM; Grossman M; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2017 Sep; 5(1):68. PubMed ID: 28877758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.